Next Article in Journal
Epigenetic Regulation of the Human Papillomavirus Life Cycle
Next Article in Special Issue
Environmental Risk of Leptospirosis in Animals: The Case of the Republic of Sakha (Yakutia), Russian Federation
Previous Article in Journal
Pathogenic Prion Protein Isoforms Are Not Present in Cerebral Organoids Generated from Asymptomatic Donors Carrying the E200K Mutation Associated with Familial Prion Disease
Previous Article in Special Issue
Leptospira Infection in African Green Monkeys in an Endemic Area: An Opportunity for Comparative Studies in a Natural Environment
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Detection of New Leptospira Genotypes Infecting Symptomatic Dogs: Is a New Vaccine Formulation Needed?

National Reference Centre for Animal Leptospirosis, Istituto Zooprofilattico Sperimentale della Lombardia ed Emilia Romagna “Bruno Ubertini”, 25121 Brescia, Italy
Istituto Zooprofilattico Sperimentale delle Venezie, Viale dell’Università, 35020 Legnaro, Italy
“San Marco” Veterinary Clinica and Laboratory, Via dell’ Industria, 35030 Veggiano, Italy
Author to whom correspondence should be addressed.
Pathogens 2020, 9(6), 484;
Submission received: 28 May 2020 / Revised: 16 June 2020 / Accepted: 17 June 2020 / Published: 18 June 2020
(This article belongs to the Special Issue Leptospira infections in Domestic and Wild Animal)


Leptospirosis in dogs has been largely described worldwide, and epidemiological studies have been mainly based on serological data. This study aims to detect and genotype leptospires affecting symptomatic dogs in Northeast Italy between 2013 and 2019. Overall, 1631 dogs were tested using real-time PCR, and leptospires from 193 dogs were subjected to Multilocus Sequence Typing and a Multiple Loci Variable-number Tandem Repeat Analysis. Leptospires were successfully isolated from 15 symptomatic dogs. Six distinct Sequence Types (STs) were found for 135 leptospires, with 3 STs characterizing Leptospira interrogans (ST17, ST198 and ST24), 2 STs characterizing Leptospira kirschneri (ST117 and ST289) and 1 ST characterizing Leptospira borgpetersenii (ST155), revealing the circulation of the serogroups Icterohaemorrhagiae, Australis, Sejroe and Pomona. The Multiple Loci Variable-number Tandem Repeat Analysis of 17 samples did not result in any additional discrimination. Genotypes were compared with those of strains present in the historical internal database, and possible transmission chains were identified from rat, mouse, hedgehog and pig. This work highlights the importance of molecular methods in revealing and identifying circulating Leptospira strains, and it also encourages the evaluation of the ability of commercially available vaccines to reduce the disease burden among dogs.

1. Introduction

Leptospirosis is a widespread zoonotic disease caused by infection with a pathogenic species of the genus Leptospira [1]. It is a worldwide public health and veterinary problem involving many domestic and wild animal species. Dogs have been known to be hosts of pathogenic leptospires since 1931, when Klarenbeek and Schuffner first isolated leptospires from the urine of a dog affected by nephritis [2]. Dogs are highly susceptible to infection, and they act as a sentinel species for the environmental risk to humans because of their high level of environmental exposure to pathogenic leptospires. Canine leptospirosis has been largely described worldwide [1,2,3], and its seroprevalence varies in accordance with geographic location, as follows: 1.8% in Australia [4], 7.3% in China [5], 9.9% in Brazil [6], 14.63% in Iran [7], 17.1% in the USA [8], 25.8% in Spain [9] and 71.1% in India [10]. In Italy, a 2002 survey conducted on kenneled dogs reported a seroprevalence of 29.4% [11], and national data collected in 2010–2011, involving more than 3000 dogs, described a seropositivity of 29.9% [12]. Nevertheless, these studies were not standardized, and some were partially biased by vaccine responses, the panel of serovars adopted for the Micro Agglutination Test (MAT) and sample collection, which was based on clinical suspects. In fact, a recent survey conducted in Italy on both ill and healthy dogs reported a lower seroprevalence of 8% [13].
Canine leptospirosis has mainly been associated with serovars Canicola and Icterohaemorrhagiae, two serogroups included within the Leptospira interrogans species. In Europe, protective vaccines for dogs against these serovars have been available for ~60 years [14]; however, recently, leptospirosis’ epidemiological situation in dogs has changed, and clinical syndromes have been described in association with serovars not included in the traditional vaccines [1,11,15,16]. Because Grippotyphosa and Bratislava have emerged as major causes of canine leptospirosis in Europe [12,17,18,19], new canine Leptospira vaccines containing antigens from up to four different serogroups, Canicola, Icterohaemorrhagiae, Australis and Grippotyphosa, have been introduced in the area [20,21]. In particular, trivalent (serogroups Canicola, Icterohaemorrhagiae and Grippothyphosa) and tetravalent (serogroups Canicola, Icterohaemorrhagiae, Grippothyphosa and Australis) vaccines have been licensed in European countries.
To date, epidemiological studies have been mainly based on serological diagnoses, particularly MAT, which is based on determining the ability of serial dilutions of the tested serum to agglutinate live leptospiral serovars in vitro. Agglutination is assessed by darkfield microscopy and suggests exposure to a serovar belonging to the corresponding serogroup (but not necessarily to the serovar tested) [22]. It is based on the specific antigenic determinants related to the structural heterogeneity of the lipopolysaccharide, and it is considered the diagnostic test of choice in dogs suspected of having leptospirosis [16,23]. Despite the widespread use of MAT to diagnose leptospirosis in dogs, this assay has limitations linked to its indirect diagnostic nature, such as possible false-negative results for initial infections, cross-reactions and paradoxical reactions early during the course of the disease [22,24,25], the variability of the selected antigenic panel and the subjective interpretation of the results. Furthermore, it generally does not discriminate between vaccinated and infected, increasing the difficulty of interpreting canine tests [26]. In addition, making direct comparisons between different studies is complicated by the variability in cut-off MAT titers used.
Several direct molecular assays, such as real-time PCR targeting various leptospiral genes, have been developed to support serological methods [27,28,29,30,31,32]. The diagnostic performances of different PCR assays are not equivalent [33], but they have been very useful in confirming diagnoses at the early stages of infection, when antibody titers are at undetectable levels [34], and in testing vaccinated patients because previous vaccination does not interfere with the PCR results [35]. Positive PCR results indicate that leptospiral DNA is present in the sample, but negative blood or urine results do not rule out leptospirosis. In fact, leptospiremia is transient, and urinary shedding is delayed after acute infection and can be intermittent. Furthermore, having received an antibiotic treatment recently may affect the detection of leptospiral DNA [1]. For this reason, PCR results should always be interpreted cautiously and in conjunction with MAT results, and they should take into account the clinical context. Furthermore, although its use is highly feasible, routine diagnostic PCR provides no information on the infecting serovar.
Some methods of molecular typing, such as Multilocus Sequence Typing (MLST) [36] and Multiple Loci Variable-number Tandem Repeat Analysis (MLVA) [37], offer interesting epidemiological perspectives by providing a specific and unique barcode for the infecting Leptospira through the analysis of specific fragments of particular bacterial loci. Until recently, the MLST technique was only applicable to isolated strains, because it required relatively large amounts of leptospiral DNA, making its direct use on clinical specimens impossible. This was a considerable limitation because culturing leptospires is challenging, time consuming and requires an equipped laboratory. Moreover, the isolation efficiency is very low and is dependent on the Leptospira strain and the use of an antimicrobial treatment prior to collection. Fortunately, a fast and specific method for genotyping Leptospira DNA directly from biological samples has been developed [38], allowing the rapid identification of the pathogen without strain isolation and providing the opportunity to investigate all the circulating strains, not just those successfully isolated, which represent a small percentage of the spreading strains. Through the assignment of sequence types (STs), MLST permits objective comparisons between strains of Leptospira infecting the same host in different geographic regions or different host species within the same geographic region, providing a helpful and powerful tool in investigating the epidemiology of leptospirosis. Therefore, knowledge of regional epidemiology, which can be reliably assessed only by the identification of locally prevalent strains, is necessary for understanding the infection and transmission chains and for maintaining up-to-date vaccination strategies.
The aims of this study were to provide the existent assessment of the genetic diversity in leptospires infecting dogs in Northeast Italy, highlight the need to update vaccine formulations to improve effective preventive measures and reduce the burden of leptospirosis among the canine population.

2. Results

2.1. Real-Time PCR

Real-time PCR detected pathogenic leptospiral DNA in 264 out of 1631 (16.2%) tested dogs (347 out of 2485 biological samples) (Table 1).

2.2. Isolation

In total, 15 strains were successfully isolated, all from urine samples. They were identified at serogroup and serovar level using MAT with polyclonal antisera and monoclonal antibodies (mAbs), respectively (Table 2).

2.3. Genotyping Analyzsis

2.3.1. Multilocus Sequence Typing (MLST)

Out of 193 leptospires infecting dogs subjected to a genotyping analysis, the sequence types of 106 were completely defined, 29 were partially defined (4–6 amplifiable loci) and 58 were undefined (0–3 amplifiable loci). Difficulties in amplifying all loci resulted from the low amounts of leptospiral DNA present in the samples. Samples having a partial pattern were considered because they can be still classifiable to unique known STs, which are defined by loci alleles (Table 3).
A total of six known distinct STs were detected, with three STs belonging to L. interrogans (ST17, ST198 and ST24), two STs belonging to L. kirschneri (ST117 and ST289) and one ST belonging to L. borgpetersenii (ST155).
The major portion (68.9%) of Leptospira infecting dogs was identified as ST17, which identifies L. interrogans serogroup Icterohaemorrhagiae (serovar Icterohaemorrhagiae or Copenhageni). Other portions were identified as follows: 9.6% as ST198, which identifies L. interrogans serogroup Australis serovar Australis; 7.4% as ST24, which identifies L. interrogans serogroup Australis (serovar Bratislava or Jalna); 5.2% as ST117, which identifies L. kirschneri serogroup Pomona serovar Mozdok; 4.4% as ST155, which identifies L. borgpetersenii serogroup Sejroe and 3.7% as ST289, which identifies L. kirschneri serogroup Pomona.
One sample collected from the Emilia-Romagna region in 2019 showed a new genotype (named as ST17-like) that was characterized by a new allelic combination, similar to that of ST17 (glmU: 1, pntA: 1, sucA: 2, tpiA: 2, pfkB: 10, mreA: 4, caiB: 8), but having allele 13 instead of 1 for the glmU gene. Its sucA gene was not amplifiable and, therefore, its MLST profile was incomplete.
Considering an immunity protection of one year after vaccination [39,40], 12 out of 40 dogs that had knowingly been vaccinated were theoretically protected from the clinical disease while 28 were not protected because they had been vaccinated more than 12 months before sample collections, or never vaccinated (Table 4).
Three regularly vaccinated dogs were clinically affected by L. interrogans serogroup Icterohaemorrhagiae (ST17), a serogroup included in all the vaccine formulations. The following related anamnestic and prognostic data were available: one dog was a 5-month old puppy that had regularly received the first dose of the vaccine. The dog was developing symptoms but completely recovered; the second was a hunting dog that received a booster dose two months before but with a fatal outcome because it was treated too late, and the third dog commonly frequented a river near its home and was showing the onset of hyperacute symptoms. However, thanks to therapeutic intervention, it completely recovered.
Three regularly vaccinated dogs were infected by serovars belonging to Pomona and Sejroe serogroups (ST117, ST155 and ST289) that were not included in the vaccine formulations. Four out of six vaccinated dogs infected with serovar Australis ST198 had been vaccinated with bivalent or trivalent vaccines that did not contain antigens of the Australis serogroup and one received a tetravalent vaccine, which contained L. interrogans Bratislava within Australis serogroup as the antigen.
Overall, for 39 of 135 dogs, leptospirosis was lethal (Table 4). Among them, 32 (82%) were infected by Leptospira ST17, 3 (7.7%) by Leptospira ST117 and 1 (2.6%) each by Leptospira belonging to ST24, ST155, ST198 and ST289 (Table 4). Interestingly, all the STs were able to cause fatal leptospirosis.

2.3.2. Multiple Loci Variable-Number Tandem Repeat Analysis (MLVA)

The MLVA pattern of 15 isolates and 2 DNAs from biological samples were obtained. The failure to amplify some loci was due to two different causes: the absence of the locus for biological reasons in the species under test (for example the locus Lb4 for L. interrogans and the loci 10 and Lb4 for L. kirschneri) [37] that was indicated as N (negative) or because of intrinsic causes (i.e., low amount of DNA) that do not permit a successful amplification (in this case we used the term “Not Amplifiable”). Twelve samples (11 isolates and 1 DNA) belonging to L. interrogans Icterohaemorrhagiae were genotyped as 2-1-7-N-6 for the loci 4-7-10-Lb4-Lb5, respectively. Additionally, two isolates previously typed as ST198 (L. interrogans Australis Australis) were genotyped as 2-10-10-N-5, respectively; two isolates with ST117 (L. kirschneri Pomona Mozdok) were genotype as 0-1-N-N-3, respectively, and one DNA of L. interrogans Australis Jalna/Bratislava (ST24) was genotyped as 4-10-10-N-Not Amplifiable, respectively. The MLVA patterns did not permit any further discrimination of the strains belonging to the same ST, but they corroborated the results obtained by the MAT and/or MLST analysis.

2.4. Sequencing A Tract of the lic12008 Gene on Strains Belonging to ST17

A small tract of the lic12008 genes in 93 samples (both isolates and DNAs) that belonged to ST17 was sequenced for serovar discrimination. In total, 66 gene tracts were successfully sequenced, with 62 identified as serovar Icterohaemorrhagiae and 4 as serovar Copenhageni (Table 5). No product was obtained owing to the low concentrations of leptospiral DNA from 19 isolates, and 8 DNA samples were insufficient for analysis.
Interestingly, the serovar identifications by lic12008 sequencing and MAT were in agreement for nine isolates, but not for two isolates that were identified as serovar Copenhageni using the serological method but as serovar Icterohaemorrhagiae using sequencing.
Two dogs infected with Leptospira of serovar Icterohaemorrhagiae were regularly vaccinated: one with a tetravalent vaccine and one with a bivalent vaccine, which both contained antigens of serovar Icterohaemorrhagiae. One dog infected with Leptospira serogroup Icterohaemorrhagiae, serovar undefined, was regularly vaccinated with a quadrivalent vaccine containing serovar Icterohaemorrhagiae. In total 18 of 62 dogs infected with Leptospira serovar Icterohaemorrhagiae were not optimally protected because they had been vaccinated more than 12 months before sample collection or never. For the four dogs infected with serovar Copenhageni, one had never been vaccinated against Leptospira infection, while the vaccination states of the three remaining dogs were unavailable.

2.5. Data Analysis

2.5.1. Geographical Maps Based on Found Genotypes

Figure 1 shows the distribution of the identified STs among the provinces of the five regions of Northeast Italy (Lombardy, Emilia Romagna, Veneto, Trentino Alto Adige and Friuli Venezia Giulia). Both the complete and the partial MLST profiles were reported and placed in a corresponding ST. Two genotyped samples identified as ST17 were excluded from the map because their province could not be determined. The high concentration of genotyped samples in the Veneto region was associated with the large number of samples delivered to the laboratory for Leptospira-infection diagnosis owing to the wide involvement of veterinary practitioners in the research, which was less common in the other regions. Despite some variability at the regional level, the STs identified in the tested dogs were found widespread in the investigated area. ST17, the most highly represented ST among the detected genotypes, was present in all five of the regions considered. The limited sampling in some regions may explain why some STs were not detected in all the regions considered.

2.5.2. Phylogenetic Analysis Based on Concatenated MLST Loci

A phylogenetic tree was constructed using the sequences of 3111-bp of concatenated MLST loci (Figure 2). Samples genotyped as ST17 clustered with reference strains L. interrogans Copenhageni (strains Wijnberg and M20) and Icterohaemorrhagiae (Bianchi 1 and Ictero I). Leptospires genotyped as ST155 clustered with reference strain L. borgpetersenii Sejroe strain Topino 1, and those genotyped as ST24 clustered with reference strains L. interrogans Jalna Jalna and Bratislava Riccio 37. Leptospires having ST117 clustered with strain L. kirschneri Mozdok 5621, while those having ST198 clustered with strain 367/2012, a recently obtained isolated in Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna laboratory from a hedgehog [41], genotyped as L. interrogans serovar Australis and shared six out seven loci with ST24. The phylogenetic analysis indicated that ST289 is closely related to L. kirschneri serovar Mozdok, as recently reported [42].

2.5.3. Minimum Spanning Tree Based on MLST Data

The genotypes obtained in this study were compared with the STs present in the Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna (IZSLER) database and relative to other host species, using a minimum spanning tree analysis (Figure 3).
ST17, which was very frequently identified in dogs, was also found in 20 rats, 2 mice, 2 cats, 1 hedgehog, 1 horse, 1 goat and 1 cow. ST198 was first identified by the IZSLER laboratory in nine hedgehogs collected in 2012 from a collection center at Modena, Italy [41], and it was subsequently found in three more hedgehogs, one dog and one horse. ST24 was identified also in one hedgehog, one wild boar and one fox. ST289, which was first discovered in a pig in Northern Italy in 2014 [42], is a new genotype that has been identified in five dogs. ST117 was also found in a wolf and ST155 was responsible for the infection of one mouse and one horse.

3. Discussion

The absence of available molecular typing data and the complex genomic diversity of strains responsible for canine leptospirosis motivated us to genotype strains from symptomatic dogs in Northeast Italy, sampled between 2013 and 2019, using molecular methods.
Real-time PCR targeting the lipL32 gene [27] or rrs (16S) gene [29] was used to screen the infected dogs and genotyping was conducted to identify the leptospires responsible for the infections.
The isolation of Leptospira strains was attempted, but only 15 out of 486 samples were successfully cultured, despite the immediate inoculation of the culture medium with samples. This confirmed that culturing Leptospira is difficult [22] and indicates the importance of increasing the tools available for genotyping strains directly from the DNA of biological samples.
The genotyping analysis, which was successfully performed on 15 isolates and 120 leptospiral DNAs, has increased our understanding of the epidemiological status of canine leptospirosis in Northeast Italy. It corroborated the serological evidence of the presence of high frequencies of strains from serogroup Icterohaemorrhagiae (ST17) and Australis (ST24 and ST198), but it also revealed the important roles of other serogroups, such as Pomona (ST117 and ST289) and Sejroe (ST155), as causative agents of the disease. Furthermore, this study revealed the presence of two recent genotypes, ST198 and ST289, which were discovered in hedgehogs and pigs, respectively, in Northern Italy. Thus, the results offer an interesting epidemiological perspective on the circulation of strains among different species and areas.
Among the identified genotypes, ST17, indicating the presence of L. interrogans serogroup Icterohaemorrhagiae, was confirmed as the major cause of canine leptospirosis. Previous serological surveys have consistently shown Icterohaemorrhagiae as the most reactive serogroup in dogs suspected of having leptospirosis [13,15,43,44,45,46] and interestingly, the serological profiles of human subjects suspected of having leptospiral infections also indicate that serovars Icterohaemorrhagiae and Copenhageni act as the main causative agents [47,48].
The application of an epidemiological approach, which considered data from the National Reference Centre for Animal Leptospirosis of Istituto Zooprofilattico Sperimentale della Lombardia e dell’Emilia Romagna (IZSLER) related to historical canine samples or belonging to other host species, provided insights into the infection’s transmission chain. Our findings corroborated the hypothesis that dogs are exposed to environmental contamination spread by rodents [49], notably Rattus spp., which act as the main reservoir host of Icterohaemorrhagiae/Copenhageni serovars worldwide [50]. Although the inclusion of serogroup Icterohaemorrhagiae in vaccine formulations has led to its decreasing seroprevalence in Italy [46], this serogroup is still a major cause of disease in dogs, owing to the ubiquitous nature of its maintenance host. The dog, in this case, represents a spill-over and can be used as an important sentinel species for human and other animal infections [51,52,53]. Interestingly, the IZSLER database revealed that Leptospira ST17 occurs in different hosts (mouse, cat, hedgehog, horse, goat and cow), which indicates its ability to cause infection in a wide range of animal species. The sequencing of the lic12008 gene, which was recently reported by Santos et al. [54] as useful in discriminating Icterohaemorrhagiae and Copenhageni serovars, allowed us to determine that the major portion (94%) of samples typed as ST17 represented serovar Icterohaemorrhagiae, and only a small portion (6%) represented serovar Copenhageni. The reliability of this molecular test for serovar discrimination is still unclear, and further studies are necessary, given that the serovar determinations of two isolates, as assessed by mAbs and by lic12008 sequencing, were not in agreement (Table 5).
Three regularly vaccinated dogs were infected by L. interrogans serogroup Icterohaemorrhagiae, which is included in all the commercial vaccine formulations, which, however, are commonly able to protect the animal against acute signs but may not prevent infection if the animal is exposed to high bacterial load [15]. An evaluation of the anamnestic and prognostic data of these dogs revealed that they were borderline cases. The puppy, being in a vulnerable developmental period, showed symptoms even after it developed antibodies, but the protection provided by the vaccine may have played a key role in its complete recovery. The hunting dog, which may have been exposed to high bacterial loads that could be responsible for the disease manifestation, started therapy late, resulting in its death. In this case, the delayed treatment of leptospirosis may have allowed the escape of surviving bacteria to the bactericidal effect of antibiotics. The dog that commonly frequented the river and developed acute symptoms with severe hepatonephritis, responded to therapy and completely recovered, probably owing to an active and ready immune response previously stimulated by the vaccine. With the exception of the second case, in which the delay in receiving therapy may have been fatal, vaccination appears to have played a crucial role in protecting dogs from death, given that Icterohaemorrhagiae infections in dogs are often associated with clinical courses culminating in fatal outcomes [15,55,56].
Interestingly, 13 dogs were infected by L. interrogans ST198, a new genotype first revealed in hedgehogs of Northern Italy [41] and continually serologically typed as belonging to serovar Australis and serogroup Australis. Very recently, Balboni et al. [57] identified ST198 in a symptomatic dog, providing further evidence of its involvement in canine leptospirosis in Italy. The discovery of this genotype among dogs suggested two important findings: from an epidemiological point of view, a possible direct transmission between species or by indirect infection through a contaminated shared environment, and from a clinical point of view, its presence and ability to cause the clinical presentation of leptospirosis, which can be fatal in Italian dogs.
In this study, a novel genotype, called “ST17-like” because of its similarity to ST17, was discovered in a dog of 2019. Unfortunately, it was unsuitable for submission to BIGSdb because of its incomplete MLST profile. Further confirmation and investigations are required, including the evaluation of its presence in other dogs and hosts in the same area.
More than 7% of the genotyped samples were characterized as ST24 and found worldwide in isolates serologically typed as belonging to serovars Jalna and Bratislava, within serogroup Australis [58]. Unfortunately, because the isolates were unavailable, they were not characterized using mAbs, and consequently, there is no data that can be used to define the specific infective serovars present in the sampled dogs. It is probable that these infections were largely caused by L. interrogans serovar Bratislava, because data from the past 30 years indicate the widespread exposure of dogs to this serovar in Europe [11,12,46]. This was confirmed by the isolation of this serovar from urine of infected dogs in Scotland [59] and by its presence among hedgehogs [60], pigs [12] and wild boars [61] in Italy. Bratislava is the serovar most commonly isolated from domestic animals and, for this reason, is most commonly used as the antigen to represent the Australis serogroup in MAT panels. Our study revealed that this strain is responsible for infections in several hosts other than dog, such as hedgehog, wild boar and horse, in agreement with previous serological studies [12,13,61]. Interestingly, in this study, ST24 was also identified in a fox, indicating possible transmission through a contaminated shared environment.
The coverage of the vaccine for the Australis serogroup remains to be evaluated, not only because bivalent vaccines are still widely used but also because new emerging strains, such as Leptospira serovar Australis ST198, may represent a significant cause of canine leptospirosis in Italy. Because current tetravalent vaccines contain antigens of Australis Bratislava (ST24), new research is required to evaluate their ability to protect dogs against infection by Leptospira Australis ST198.
Strains typed as ST117, indicating the presence of L. kirschneri serovar Mozdok, play an important role in causing leptospirosis in dogs. Epidemiological studies have identified this serovar across Europe [17,62,63,64,65], in dogs [19], small rodents [65,66,67], in cattle and pigs [68]. It has been involved in human cases and in canine infections in Cuba [64,66,67,69], making it a relevant risk to public health. Clinically, dogs infected with Leptospira belonging to this serogroup experience a severe disease characterized by lethargy, fever, lack of appetite, diffuse hemorrhage and renal and liver failure [70,71]. Serovar Pomona, included in the same serogroup, has emerged in the USA as cause of clinical symptoms in dogs [51], and it has been added to vaccine formulations. In Italy, in 2002, Scanziani and colleagues reported some serological positivity of dogs to Pomona serogroup [11], and recently, Bertelloni found an increasing incidence of Pomona among dogs in the north central area of Italy [13]. In 2010, Ellis [17] had proposed the usefulness of including other serovars, such as Pomona, in the vaccine formulation, but he also believed that additional clinical, cultural and serological studies were needed to support their inclusion. Here, the obtained data agree with previous serological data and support the inclusion of a Pomona serogroup strain, especially one belonging to serovar Mozdok, in dog vaccines in Europe.
Interestingly, five dogs were infected by leptospires genotyped as ST289, a new genotype recently found for the first time by IZSLER laboratory in a pig of 2014, living in Northern Italy [42]. It was typed using core genome MLST as very similar, but not identical, to L. kirschneri serovar Mozdok, within serogroup Pomona. The discovery of this genotype in Italian dogs suggested its ability to cause clinical manifestations in dogs and the possible direct transmission among animals or an indirect passage, possibly in a herd context. More studies should be performed to clarify the role of this new strain in causing canine leptospirosis, but our findings support the inclusion of serogroup Pomona in vaccine formulations
In the present study, ST155 was found in six dogs. It characterizes L. borgpetersenii serogroup Sejroe, but the serovar status was not deducible from the MLST profile. Nevertheless, the international database BIGSdb [58] reported that isolates typed as ST155 belong to serovars Polonica and Saxkoebing. Using the information from our database, ST155 was compatible with both serovar Sejroe and serovar Polonica, but not with serovar Saxkoebing. In fact, the reference strains serovar Sejroe strain Topino 1, serovar Sejroe strain M24 (Figure 2) and serovar Polonica strain 493 Poland (not reported) were previously typed as ST155, while the reference strain serovar Saxkoebing strain Mus 24 was typed as ST219 (Figure 2). Strains serotyped as Sejroe were previously described as being causative agents of canine leptospirosis worldwide [72,73], and interestingly, this strain was found in an asymptomatic dog in Brazil [74,75]. The minimum spanning tree, color-coded by animal host, revealed the shared presence of these STs among dogs, horses and mice.
Our results indicated that the use of the serovar of the serogroup Sejroe strain in MAT analyses to test local canine populations should be reconsidered. In fact, the MAT panel commonly contains serovar Hardjo (ST152), but the inclusion of serovar Sejroe (ST155) would be more useful for diagnosing canine leptospirosis in our area.
Serogroup Canicola, historically included in commercial vaccine formulations, was not found in this work, and this was in agreement with previous serological studies that describe a decline in the prevalence of this serogroup in European countries, possibly because of the widespread protection resulting from the vaccination of the reservoir host [76], i.e., dog. The risk of stopping vaccinations against host-adapted Leptospira in its target host is that its prevalence may rapidly increase once the population’s immunity falls; therefore, the vaccination of dogs against serovar Canicola should continue [17].
Serovar Grippotyphosa is maintained by a number of small rodent species in mainland Europe [77,78,79]. Seroprevalence studies have indicated Grippotyphosa infections in several European countries, including Italy [11], and consequently, it has been included in commercial vaccines. However, in this molecular survey, this strain was not detected among the sampled canine population nor in other species.
The geographical map indicated a widespread distribution of the identified genotypes throughout the considered area, except for ST289, mostly concentrated in Emilia-Romagna region and ST117, found only in Veneto region. Nevertheless, these differences might be attributed to the variability in the numbers of genotyped samples rather than a geographic-dependent diversity in ST circulation. Proper investigations will determine the presence of specific environmental niches for canine leptospirosis or particular risk factors, but the common practice of owners traveling with their pets for recreational activities, such as hiking and hunting, often out of their town or province, should be taken into consideration during risk evaluation. Therefore, when planning dog vaccinations or investigating a suspected clinical case, all of the identified genotypes should be considered epidemiologically relevant.

4. Materials and Methods

4.1. Sampling, DNA Extraction and Real-Time PCR

In total, 2485 biological samples from 1631 dogs with suspected clinical leptospirosis were tested at IZSLER located in Brescia (Italy) and at Istituto Zooprofilattico Sperimentale delle Venezie (IZSVE) located in Legnaro (Padua, Italy) between January 2013 and December 2019.
Samples were collected by veterinary practitioners in the north central area of Italy (Lombardy and Emilia-Romagna regions) and in Northeast Italy (Veneto, Friuli Venezia Giulia and Trentino- Alto Adige regions) during routine diagnostic activities, owing to a systematic passive survey funded by the Italian Ministry of Health and coordinated by the IZSVE, involving many veterinary practitioners of the region. When available, data on the vaccination states and clinical follow-ups of dogs were also recorded.
DNA extractions and real-time PCR targeting the lipL32 gene were carried out at IZSLER as previously described by Bertasio et al. [42], while at IZSVE, different DNA extraction methods and kits were used in accordance with the variety of samples. A commercially available High Pure PCR Template Preparation kit (Roche Diagnostics, Mannheim, Germany) was used, in accordance with the manufacturer’s instructions, to extract 2 mL of urine or 1 cm3 tissue homogenate. From 1 mL of EDTA-treated blood, DNA was extracted using a commercially available QIAamp DNA Mini kit (Qiagen, Hilden, Germany), in accordance with the manufacturer’s instructions. In the case of poor-cellular matrices, as in urine and blood samples, 20 µg of a poly-A carrier (Roche, Diagnostics, Mannheim, Germany) was added to each sample to increase the recovery efficiency of nucleic acids. All the DNA extraction preparations included a negative control (water). All the DNAs extracted from biological samples were subjected to a TaqMan-based real-time PCR assay targeting an 87-bp fragment that corresponded to a portion of the gene encoding the 16S rDNA [29].
The PCR was performed in a 25 µL final volume, containing 3 µL of extracted DNA, 12. 5 µL of 2× Master Mix TaqMan Universal 2× (Thermo Fisher Scientific, Waltham, MA, USA), 300 nM of each primer and 100 nM of a 5′ FAM–3′-TAMRA probe. All the amplification assays included a negative control (water), a negative bacterial genomic control (DNA of Leptospira biflexa serovar Patoc) and a positive control (DNA of L. interrogans serovar Icterohaemorrhagiae), and each sample was tested in duplicate. The assay was performed on a 7900HT Fast Real-time PCR System (Thermo Fisher Scientific) with the following thermal conditions: a hot-start step at 50 °C for 2 min, a holding step at 95 °C for 10 min and 45 cycles of 95 °C for 15 s and 60 °C for 60 s. Samples with Ct < 38 were considered positive. Samples having Ct values within the 38–40 range were considered doubtful, whereas samples having no FAM fluorescence signal or with Ct ≥ 40 were considered negative.
The two methods were validated using reference materials and their performance monitored by a regular participation to proficiency testing programs organized by the National Reference Laboratory, with an agreement index (K Cohen) equal to 1.

4.2. Isolation and Serological Typing of Isolates

In total, 486 samples from 449 clinically affected dogs were chosen to attempt the isolation of the causal agent as previously described [42]. The specific matrices of these samples were 416 urines, 35 kidney and 11 livers, while for 24 samples, the data were unavailable.
The preliminary serogroup assignment was carried out using MAT with polyclonal serogroup-specific antibodies, as previously described [42]. The serovars were classified using MAT with different panels of mAbs for Icterohaemorrhagiae, Pomona and Australis serogroups. The mAbs used were the following: five mAbs (F20 C4, F52 C1, F70 C24, F70 C26 and F82 C1) for the Icterohaemorrhagiae serogroup [80], five mAbs (F43 C9, F46 C9, F48 C6, F58 C1 and F61 C7) for the Pomona serogroup [81] and six mAbs (F81 C3, F81 C5, F81 C6, F81 C8, F90 C6 and F90 C8) for the Australis serogroup [82]. These mAbs and the polyclonal anti-sera were previously purchased from the OIE Leptospirosis Reference Centre, Royal Tropical Institute (KIT), (Amsterdam, The Netherlands), and the protocol was in accordance with the standard serological methods used in this reference laboratory. To interpret the results, we referred to the expected maximum dilution titers provided by the Leptospirosis Reference Centre of KIT.

4.3. Genotyping

4.3.1. MLST

Until 2015, MLST analyses were applied only to DNA samples with Ct ≤ 35 as assessed by real-time PCR, and starting from 2016, the use of MLST was extended to all DNA samples. If more than one biological matrix was available for the same dog, the analysis was attempted on all the samples to maximize the probability of success. In total, 223 samples (15 isolates and 208 leptospiral DNAs) belonging to 193 dogs were submitted for MLST analysis (Table 6).
The analysis was performed using the 7-loci scheme proposed by Boonsilp in 2013 [36], which is based on the housekeeping genes glmU, pntA, sucA, tpiA, pfkB, mreA and caiB, as previously described [42]. Nucleotide sequences were assembled using the SeqMan module of the Lasergene sequencing analysis software package (DNASTAR Inc., Madison, WI, USA) or using Bionumerics software ver. 7.6 (Applied Math, Biomerieux, Sint-Martens-Latem, Belgium). For allelic number and ST identification, assembled and trimmed sequences were queried against the BIGSdb available on the Leptospira MLST website ( sited at the University of Oxford [58] or by an automated analysis using Bionumerics. Comparisons between the STs found and those present in BIGSdb as reference isolates were used to deduce the species of the Leptospira being tested. To perform comparisons among historical serological studies (where serovars and serogroups were defined) and genotyping data (where species and genomic profiles were defined), we chose to assign to each identified ST a classification at the serogroup and serovar levels obtained from BIGSdb, knowing that this information was deduced and did not result from active serological typing.

4.3.2. MLVA

A VNTR analysis was performed on 21 samples (15 isolates and 6 DNAs). Five discriminatory loci (VNTR-4, -7, -10, Lb4 and Lb5) described by Salaün and colleagues in 2006 [37] were considered, as previously described [42].

4.4. Sequencing of a Tract of the lic12008 Gene

A tract of the lic12008 gene of samples genotyped as ST17 (characterized as L. interrogans serogroup Icterohaemorrhagiae) was sequenced. The tract was recently found to be involved in the genetic distinction between serovars Icterohaemorrhagiae and Copenhageni [54], which are indistinguishable by MLST and MLVA. The analysis determines the presence of a single base insertion of a thymine nucleotide within a poly-thymine tract (9-bp long) in the lic12008 of all L. interrogans serovar Icterohaemorrhagiae isolates but not in Copenhageni strains. We used gene-specific primers (forward 5′-TAGGTTGGCACGAAGGTTCT-3′ and reverse 5′-CTTAAACTTTCCACTTTCCGGA-3′) to amplify a short 163-bp genomic tract containing the described discriminatory INDEL.
The PCR amplification was performed using a KAPA2G Robust HotStart PCR kit (Kapabiosystems Resnova, Rome, Italy) in a 25 µL total volume containing 0.4 µM each primer and 5 µL of DNA. The thermal conditions were as follows: 1 cycle at 95 °C for 7 min, 45 cycles at 95 °C for 30 s, 53 °C for 30 s and 72 °C for 30 s, followed by a final elongation at 72 °C for 5 min. For the sequencing procedure, we followed the same protocol used for the MLST analysis. Nucleotide sequences were assembled using the SeqMan module of the Lasergene sequencing analysis software package (DNASTAR) and were aligned with the sequences of Copenhageni and an Icterohaemorrhagiae reference strains to permit a comparison and to define the serovar of the tested Leptospira strain.

4.5. Analysis of Data

4.5.1. Geographical Map

The provinces in which the dogs were living were recorded to construct a map that displayed the distributions of the identified genotypes. The map was produced using the commercial software ESRITMArcMap 10.5.1. The spatial layer containing the provinces was joined (using province ID attribute) with the sample data. Specific style roles were applied to generate different pie charts based on the presence of different STs. The size of each chart represents the total number of genotyped samples per province. Each chart reports the results (as percentages) per ST (denoted by different colors).

4.5.2. Phylogenetic Analysis of Concatenated MLST Loci

The concatenated loci assessed by MLST on our samples were compared with those of reference strains purchased from the Leptospirosis Reference Centre of KIT using the UPGMA method with a bootstrap of 1000 replicates by Bionumerics ver. 7.6 (Applied Maths, Sint-Martens-Latem, Belgium). The resulting tree reported sample details, such as the identification number, the species, the serological classification (real for isolates and presumptive for DNA samples) and the MLVA pattern.

4.5.3. Minimum Spanning Tree based on STs

An analysis of the characteristics of alleles assessed by MLST was performed by the creation of a minimum spanning tree using Bionumerics software ver. 7.6 (Applied Maths). The analysis was applied only to samples having a complete MLST profile, and to perform an epidemiological evaluation, we also considered data for some samples already present in the IZSLER database but external to the period included in this paper (six isolated strains from dogs: 2, 1, 1, 1 and 1 from 1992, 1995, 1996, 1999 and 2007, respectively) or belonging to other hosts species (20 from rat, 3 from mouse, 2 from cat, 14 from hedgehog, 3 from horse, 1 from cow, 1 from goat, 1 from pig, 1 from wolf and 1 from wild boar). The IZSLER database is an internal database file that includes updated information on the genotyping and serological typing of isolated strains preserved in liquid nitrogen, on field samples from various animal species collected from 1989 and on reference strains purchased from by the Leptospirosis Reference Centre of KIT. Furthermore, starting in 2016, data from the molecular typing of leptospiral DNAs extracted directly from biological samples of a series of animal hosts have been added.

5. Conclusions

To the best of our knowledge this is the first study that describes the genetic diversity of pathogenic Leptospira in dogs in Italy, and it has increased our understanding of the related epidemiological situation among the Italian canine population. No area of specific risk was revealed in Northeast Italy, and the widespread presence of already known infecting serogroups, like Icterohaemorrhagiae and Australis, was confirmed. Interestingly, it highlighted the circulation of infecting strains belonging to other serogroups, such as Pomona and Sejroe, that are not included in the commercial vaccines currently available in Italy. The strains of these two serogroups were responsible for clinical leptospirosis, which was sometimes fatal, in dogs. Furthermore, new strains recently observed in other hosts in Italy, like ST198 from hedgehogs and ST289 from pigs, may play important roles in causing canine leptospirosis in Italy.

Author Contributions

Conceptualization, A.N., M.B.B., M.D. and L.L.; methodology, C.B., L.B. and M.M.; software, C.B. and M.M.; formal analysis, C.B., L.L. and L.C.; investigation, A.N., L.L. and T.F.; resources, A.N., L.L., M.B.B., M.D. and T.F.; data curation, C.B. and L.L.; writing—original draft preparation, C.B.; writing—review and editing, M.M.B., L.L., L.C., T.F., M.D. and A.N.; supervision, M.B.B. and A.N.; project administration, A.N. and M.B.B.; funding acquisition, M.B.B., M.D. and A.N. All authors have read and agreed to the published version of the manuscript.


This research was funded by the Italian Ministry of Health, grant number IZSVE RC 16/12, IZSVE RC 05/2017 and IZSLER PRC2017016.


We thank Arturo Scalvenzi, Marcello Fin, Eufrasia Peroni Ammaturo, Cosima Tomasoni, Silvia Marchione and Isabella Giurisato for their skilled technical assistance with the bacterial isolation and serological typing.

Conflicts of Interest

The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript or in the decision to publish the results.


  1. Schuller, S.; Francey, T.; Hartmann, K.; Hugonnard, M.; Kohn, B.; Nally, J.E.; Sykes, J. European consensus statement on leptospirosis in dogs and cats. J. Small Anim. Pract. 2015, 56, 159–179. [Google Scholar] [CrossRef] [PubMed]
  2. Klarenbeek, A.; Schuffner, W.A.P. Appearance in Holland of Leptospira differing from Weil Strain. Ned. Tijdschr. Geneeskd. 1933, 77, 4271–4276. [Google Scholar]
  3. Azócar-Aedo, L.; Monti, G. Meta-Analyses of Factors Associated with Leptospirosis in Domestic Dogs. Zoonoses Public Health 2016, 63, 328–336. [Google Scholar] [CrossRef] [PubMed]
  4. Zwijnenberg, R.J.G.; Smythe, L.D.; Symonds, M.I.; Dohnt, M.F.; Toribio, J.L.M.L. Cross-sectional study of canine leptospirosis in animal shelter populations in mainland Australia. Aust. Vet. J. 2008, 86, 317–323. [Google Scholar] [CrossRef] [PubMed]
  5. Shi, D.; Liu, M.; Guo, S.; Liao, S.; Sun, M.; Liu, J.; Wang, L.; Wang, Z.; Wang, S.; Yang, D.; et al. Serological survey of canine leptospirosis in Southern China. Pak. Vet. J. 2012, 32, 280–282. [Google Scholar]
  6. De Abreu, J.A.P.; da Silva Krawczak, F.; Guedes, I.B.; de Souza-Filho, A.F.; de Souza, G.O.; de Campos Binder, L.; de Oliveira, C.S.; Sponchiado, J.; Melo, G.L.; Labruna, M.B.; et al. Frequency of anti-Leptospira spp. antibodies in dogs and wild small mammals from rural properties and conservation units in southern Brazil. One Health 2019, 8, 100104. [Google Scholar] [CrossRef]
  7. Khalili, M.; Sakhaee, E.; Amiri, F.B.; Safat, A.A.; Afshar, D.; Esmaeili, S. Serological evidence of leptospirosis in Iran; A systematic review and meta-analysis. Microb. Pathog. 2020, 138, 103833. [Google Scholar] [CrossRef]
  8. Davis, M.A.; Evermann, J.F.; Petersen, C.R.; VancerSchalie, J.; Besser, T.E.; Huckabee, J.; Daniels, J.B.; Hancock, D.D.; Leslie, M.; Baer, R. Serological survey for antibodies to Leptospira in dogs and raccoons in Washington State. Zoonoses Public Health 2008, 55, 436–442. [Google Scholar] [CrossRef]
  9. López, M.C.; Vila, A.; Rodón, J.; Roura, X. Leptospira seroprevalence in owned dogs from Spain. Heliyon 2019, 5, e02373. [Google Scholar] [CrossRef] [Green Version]
  10. Ambily, R.; Mini, M.; Joseph, S.; Krishna, S.V.; Abhinai, G. Canine leptospirosis—A seroprevalence study from Kerala, India. Vet. World 2013, 6, 42–44. [Google Scholar] [CrossRef]
  11. Scanziani, E.; Origgi, F.; Giusti, A.M.; Iacchia, G.; Vasino, A.; Pirovano, G.; Scarpa, P.; Tagliabue, S. Serological survey of leptospiral infection in kennelled dogs in Italy. J. Small Anim. Pract. 2002, 43, 154–157. [Google Scholar] [CrossRef] [PubMed]
  12. Tagliabue, S.; Figarolli, B.M.; D’Incau, M.; Foschi, G.; Gennero, M.S.; Giordani, R.; Natale, A.; Papa, P.; Ponti, N.; Scaltrito, D.; et al. Serological surveillance of Leptospirosis in Italy: Two–year national data (2010-2011). Vet. Ital. 2016, 52, 129–138. [Google Scholar] [CrossRef] [PubMed]
  13. Bertelloni, F.; Cilia, G.; Turchi, B.; Pinzauti, P.; Cerri, D.; Fratini, F. Epidemiology of leptospirosis in North-Central Italy: Fifteen years of serological data (2002–2016). Comp. Immunol. Microbiol. Infect. Dis. 2019, 65, 14–22. [Google Scholar] [CrossRef] [PubMed]
  14. Jull, D.J.; Heath, K.R. The Evaluation of a Combined L.canicola and L.icterohaemorrhagiae Vaccine on Hamsters and Dogs. J. Small Anim. Pract. 1960, 1, 245–258. [Google Scholar] [CrossRef]
  15. André-Fontaine, G. Canine leptospirosis-Do we have a problem? Vet. Microbiol. 2006, 117, 19–24. [Google Scholar] [CrossRef]
  16. Sykes, J.E.; Hartmann, K.; Lunn, K.F.; Moore, G.E.; Stoddard, R.A.; Goldstein, R.E. 2010 ACVIM Small Animal Consensus Statement on Leptospirosis: Diagnosis, Epidemiology, Treatment, and Prevention. J. Vet. Intern. Med. 2011, 25, 1–13. [Google Scholar] [CrossRef] [Green Version]
  17. Ellis, W.A. Control of canine leptospirosis in Europe: Time for a change? Vet. Rec. 2010, 167, 602–605. [Google Scholar] [CrossRef] [Green Version]
  18. Mayer-Scholl, A.; Luge, E.; Draeger, A.; Nöckler, K.; Kohn, B. Distribution of Leptospira Serogroups in Dogs from Berlin, Germany. Vector-Borne Zoonotic Dis. 2013, 13, 200–202. [Google Scholar] [CrossRef] [Green Version]
  19. Renaud, C.; Andrews, S.; Djelouadji, Z.; Lecheval, S.; Corrao-Revol, N.; Buff, S.; Demont, P.; Kodjo, A. Prevalence of the Leptospira serovars bratislava, grippotyphosa, mozdok and pomona in French dogs. Vet. J. 2013, 196, 126–127. [Google Scholar] [CrossRef]
  20. Klaasen, H.L.B.M.; Van Der Veen, M.; Molkenboer, M.J.C.H.; Sutton, D. A novel tetravalent Leptospira bacterin protects against infection and shedding following challenge in dogs. Vet. Rec. 2013, 172, 181. [Google Scholar] [CrossRef] [Green Version]
  21. Klaasen, H.L.B.M.; van der Veen, M.; Sutton, D.; Molkenboer, M.J.C.H. A new tetravalent canine leptospirosis vaccine provides at least 12 months immunity against infection. Vet. Immunol. Immunopathol. 2014, 158, 26–29. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Levett, P.N. Leptospirosis. Clin. Microbiol. Rev. 2001, 14, 296–326. [Google Scholar] [CrossRef] [Green Version]
  23. Leptospirosis. In OIE Terrestrial Manual; World Organization for Animal Health: Paris, France, 2018; pp. 503–516.
  24. Strutzberg-Minder, K.; Tschentscher, A.; Beyerbach, M.; Homuth, M.; Kreienbrock, L. Passive surveillance of Leptospira infection in swine in Germany. Porc. Health Manag. 2018, 4, 10. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Levett, P.N. Usefulness of Serologic Analysis as a Predictor of the Infecting Serovar in Patients with Severe Leptospirosis. Clin. Infect. Dis. 2003, 36, 447–452. [Google Scholar] [CrossRef] [PubMed]
  26. Martin, L.E.R.; Wiggans, K.T.; Wennogle, S.A.; Curtis, K.; Chandrashekar, R.; Lappin, M.R. Vaccine-Associated Leptospira Antibodies in Client-Owned Dogs. J. Vet. Intern. Med. 2014, 28, 789–792. [Google Scholar] [CrossRef] [Green Version]
  27. Stoddard, R.A.; Gee, J.E.; Wilkins, P.P.; McCaustland, K.; Hoffmaster, A.R. Detection of pathogenic Leptospira spp. through TaqMan polymerase chain reaction targeting the LipL32 gene. Diagn. Microbiol. Infect. Dis. 2009, 64, 247–255. [Google Scholar] [CrossRef]
  28. Levett, P.N.; Morey, R.E.; Galloway, R.L.; Turner, D.E.; Steigerwalt, A.G.; Mayer, L.W. Detection of pathogenic leptospires by real-time quantitative PCR. J. Med. Microbiol. 2005, 54, 45–49. [Google Scholar] [CrossRef] [Green Version]
  29. Smythe, L.D.; Smith, I.L.; Smith, G.A.; Dohnt, M.F.; Symonds, M.L.; Barnett, L.J.; McKay, D.B. A quantitative PCR (TaqMan) assay for pathogenic Leptospira spp. BMC Infect. Dis. 2002, 2, 13. [Google Scholar] [CrossRef] [Green Version]
  30. Merien, F.; Portnoi, D.; Bourhy, P.; Charavay, F.; Berlioz-Arthaud, A.; Baranton, G. A rapid and quantitative method for the detection of Leptospira species in human leptospirosis. FEMS Microbiol. Lett. 2005, 249, 139–147. [Google Scholar] [CrossRef] [Green Version]
  31. Ahmed, A.; Engelberts, M.F.M.; Boer, K.R.; Ahmed, N.; Hartskeerl, R.A. Development and validation of a real-time PCR for detection of pathogenic Leptospira species in clinical materials. PLoS ONE 2009, 4, e7093. [Google Scholar] [CrossRef]
  32. Slack, A.T.; Symonds, M.L.; Dohnt, M.F.; Smythe, L.D. Identification of pathogenic Leptospira species by conventional or real-time PCR and sequencing of the DNA gyrase subunit B encoding gene. BMC Microbiol. 2006, 6, 95. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Bourhy, P.; Bremont, S.; Zinini, F.; Giry, C.; Picardeau, M. Comparison of real-time PCR assays for detection of pathogenic Leptospira spp. in blood and identification of variations in target sequences. J. Clin. Microbiol. 2011, 49, 2154–2160. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Harkin, K.R.; Roshto, Y.M.; Sullivan, J.T.; Purvis, T.J.; Chengappa, M.M. Comparison of polymerase chain reaction assay, bacteriologic culture, and serologic testing in assessment of prevalence of urinary shedding of leptospires in dogs. J. Am. Vet. Med. Assoc. 2003, 222, 1230–1233. [Google Scholar] [CrossRef]
  35. Midence, J.N.; Leutenegger, C.M.; Chandler, A.M.; Goldstein, R.E. Effects of recent Leptospira vaccination on whole blood real-time PCR testing in healthy client-owned dogs. J. Vet. Intern. Med. 2012, 26, 149–152. [Google Scholar] [CrossRef] [PubMed]
  36. Boonsilp, S.; Thaipadungpanit, J.; Amornchai, P.; Wuthiekanun, V.; Bailey, M.S.; Holden, M.T.G.; Zhang, C.; Jiang, X.; Koizumi, N.; Taylor, K.; et al. A single multilocus sequence typing (MLST) scheme for seven pathogenic Leptospira species. PLoS Negl. Trop. Dis. 2013, 7, e1954. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  37. Salaün, L.; Mérien, F.; Gurianova, S.; Baranton, G.; Picardeau, M. Application of Multilocus Variable-Number Tandem-Repeat Analysis for Molecular Typing of the Agent of Leptospirosis. J. Clin. Microbiol. 2006, 44, 3954–3962. [Google Scholar] [CrossRef] [Green Version]
  38. Weiss, S.; Menezes, A.; Woods, K.; Chanthongthip, A.; Dittrich, S.; Opoku-Boateng, A.; Simuli, M.; Chalke, V. An Extended Multilocus Sequence Typing (MLST) Scheme for Rapid Direct Typing of Leptospira from Clinical Samples. PLoS Negl. Trop. Dis. 2016, 10, e0004996. [Google Scholar] [CrossRef]
  39. Klaasen, H.L.B.M.; Molkenboer, M.J.C.H.; Vrijenhoek, M.P.; Kaashoek, M.J. Duration of immunity in dogs vaccinated against leptospirosis with a bivalent inactivated vaccine. Vet. Microbiol. 2003, 95, 121–132. [Google Scholar] [CrossRef]
  40. Wilson, S.; Stirling, C.; Thomas, A.; King, V.; Plevová, E.; Chromá, L.; Siedek, E.; Illambas, J.; Salt, J.; Sture, G. Duration of immunity of a multivalent (DHPPi/L4R) canine vaccine against four Leptospira serovars. Vaccine 2013, 31, 3126–3130. [Google Scholar] [CrossRef]
  41. Boniotti, M.B.; Gelmini, L.; Carra, E.; Figarolli, B.M.; D’incau, M.; Tagliabue, S. Leptospira Interrogans Serogroup Australis In Hedgehog In Northern Italy. Proocedings of the International Leptospirosis Society of the Conference, Fukuoka, Japan, 7–11 October 2013. [Google Scholar]
  42. Bertasio, C.; Papetti, A.; Scaltriti, E.; Tagliabue, S.; D’Incau, M.; Boniotti, M.B. Serological Survey and Molecular Typing Reveal New Leptospira Serogroup Pomona Strains among Pigs of Northern Italy. Pathogens 2020, 9, 332. [Google Scholar] [CrossRef]
  43. Modric, Z.; Culjak, K.; Hahn, V. Leptospirosis in a dog caused by Leptospira interrogans serotype pomona. Vet. Glas. 1987, 41, 43–47. [Google Scholar]
  44. Vojinović, D.; Bogićević, N.; Vasić, A.; Manić, M.; Elezović Radovanović, M.; Rogožarski, D.; Marić, J.; Valčić, M. Seroepidemiological survey of leptospiral infection in stray dogs in Serbia. Turkish J. Vet. Anim. Sci. 2015, 39, 719–723. [Google Scholar] [CrossRef]
  45. Burriel, A.R.; Dalley, C.; Woodward, M.J. Prevalence of Leptospira species among farmed and domestic animals in Greece. Vet. Rec. 2003, 153, 146–148. [Google Scholar] [CrossRef]
  46. Cerri, D.; Ebani, V.V.; Fratini, F.; Pinzauti, P.; Andreani, E. Epidemiology of leptospirosis: Observations on serological data obtained by a “diagnostic laboratory for leptospirosis” from 1995 to 2001. New Microbiol. 2003, 26, 383–389. [Google Scholar]
  47. Felzemburgh, R.D.M.; Ribeiro, G.S.; Costa, F.; Reis, R.B.; Hagan, J.E.; Melendez, A.X.T.O.; Fraga, D.; Santana, F.S.; Mohr, S.; dos Santos, B.L.; et al. Prospective Study of Leptospirosis Transmission in an Urban Slum Community: Role of Poor Environment in Repeated Exposures to the Leptospira Agent. PLoS Negl. Trop. Dis. 2014, 8, e2927. [Google Scholar] [CrossRef] [Green Version]
  48. Oliveira, M.A.A.; Leal, É.A.; Correia, M.A.; Serufo Filho, J.C.; Dias, R.S.; Serufo, J.C. Human leptospirosis: Occurrence of serovars of Leptospira spp. in the state of Minas Gerais, Brazil, from 2008 to 2012. Braz. J. Microbiol. 2017, 48, 483–488. [Google Scholar] [CrossRef] [PubMed]
  49. Suepaul, S.M.; Carrington, C.V.F.; Campbell, M.; Borde, G.; Adesiyun, A.A. Serovars of Leptospira isolated from dogs and rodents. Epidemiol. Infect. 2010, 138, 1059–1070. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Boey, K.; Shiokawa, K.; Rajeev, S. Leptospira infection in rats: A literature review of global prevalence and distribution. PLoS Negl. Trop. Dis. 2019, 13, e0007499. [Google Scholar] [CrossRef]
  51. Ghneim, G.S.; Viers, J.H.; Chomel, B.B.; Kass, P.H.; Descollonges, D.A.; Johnson, M.L. Use of a case-control study and geographic information systems to determine environmental and demographic risk factors for canine leptospirosis. Vet. Res. 2007, 38, 37–50. [Google Scholar] [CrossRef] [Green Version]
  52. Major, A.; Schweighauser, A.; Francey, T. Increasing incidence of canine leptospirosis in Switzerland. Int. J. Environ. Res. Public Health 2014, 11, 7242–7260. [Google Scholar] [CrossRef] [Green Version]
  53. Schuller, S.; Arent, Z.J.; Gilmore, C.; Nally, J. Prevalence of antileptospiral serum antibodies in dogs in Ireland. Vet. Rec. 2015, 177, 126. [Google Scholar] [CrossRef] [PubMed]
  54. Santos, L.A.; Adhikarla, H.; Yan, X.; Wang, Z.; Fouts, D.E.; Vinetz, J.M.; Alcantara, L.C.J.; Hartskeerl, R.A.; Goris, M.G.A.; Picardeau, M.; et al. Genomic comparison among global isolates of L. interrogans serovars Copenhageni and Icterohaemorrhagiae identified natural genetic variation caused by an indel. Front. Cell. Infect. Microbiol. 2018, 8, 193. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  55. Rissi, D.R.; Brown, C.A. Diagnostic features in 10 naturally occurring cases of acute fatal canine leptospirosis. J. Vet. Diagn. Investig. 2014, 26, 799–804. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  56. CE, N.; GJ, K.; JJ, K. Serum biochemical changes in dogs with experimental Leptospira interrogans serovar icterohaemorrhagiae infection. Am. J. Vet. Res. 1981, 42, 1125–1129. [Google Scholar]
  57. Balboni, A.; Zamagni, S.; Bertasio, C.; Boniotti, M.B.; Troìa, R.; Battilani, M.; Dondi, F. Identification of Serogroups Australis and Icterohaemorrhagiae in Two Dogs with a Severe Form of Acute Leptospirosis in Italy. Pathogens 2020, 9, 351. [Google Scholar] [CrossRef]
  58. Jolley, K.A.; Maiden, M.C.J. BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinform. 2010, 11, 595. [Google Scholar] [CrossRef] [Green Version]
  59. Van den Broek, A.H.M.; Thrusfield, M.V.; Dobbiet, G.R.; Ellisi, W.A. A serological and bacteriological survey of leptospiral infection in dogs in Edinburgh and Glasgow. J. Small Anim. Pract. 1991, 32, 118–124. [Google Scholar] [CrossRef]
  60. Tagliabue, S.; Farina, R. Inchiesta sieroepidemiologica sulla diffusione della leptospirosi ta gli animali domestici ed alcune specie selvatiche. Sel. Vet. 1995, 36, 11–12. [Google Scholar]
  61. Chiari, M.; Figarolli, B.M.; Tagliabue, S.; Alborali, G.L.; Bertoletti, M.; Papetti, A.; D’Incau, M.; Zanoni, M.; Boniotti, M.B. Seroprevalence and risk factors of leptospirosis in wild boars (Sus scrofa) in northern Italy. Hystrix 2016, 27, 2. [Google Scholar] [CrossRef]
  62. Das Neves Paiva-Cardoso, M.; Arent, Z.; Gilmore, C.; Hartskeerl, R.; Ellis, W.A. Altodouro, a new Leptospira serovar of the Pomona serogroup isolated from rodents in northern Portugal. Infect. Genet. Evol. 2013, 13, 211–217. [Google Scholar] [CrossRef]
  63. Rocha, T.; Ellis, W.A.; Montgomery, J.; Gilmore, C.; Regalla, J.; Brem, S. Microbiological and serological study of leptospirosis in horses at slaughter: First isolations. Res. Vet. Sci. 2004, 76, 199–202. [Google Scholar] [CrossRef]
  64. Rocha, T. Isolation of Leptospira interrogans serovar mozdok from aborted swine fetuses in Portugal. Vet. Rec. 1990, 126, 602. [Google Scholar]
  65. Majetic, Z.S.; Galloway, R.; Sabljic, E.R.; Milas, Z.; Perko, V.M.; Habus, J.; Margaletic, J.; Pernar, R.; Turk, N. Epizootiological survey of small mammals as Leptospira spp. reservoirs in Eastern Croatia. Acta Trop. 2014, 131, 111–116. [Google Scholar] [CrossRef] [PubMed]
  66. Pritchard, D.G.; Todd, N.; Barlow, A.; Little, S.A. Outbreak of Leptospira interrogans serovar mozdok in sows in Dorset, England. Isr. J. Vet. Med. 1987, 43, 343. [Google Scholar]
  67. Barlow, A.M. Reproductive failure in sows associated with Leptospira Mozdok from a wildlife source. Pig J. 2004, 54, 123–131. [Google Scholar]
  68. Hathaway, S.C.; Todd, J.N.; Headlam, S.A.; Jeffrey, M. Possible role of leptospires of the Pomona serogroup in sporadic bovine abortion in the south west of England. Vet. Rec. 1984, 115, 623–626. [Google Scholar] [CrossRef]
  69. Da Cunha, C.E.P.; Felix, S.R.; Neto, A.C.P.S.; Campello-Felix, A.; Kremer, F.S.; Monte, L.G.; Amaral, M.G.; Nobre, M.D.O.; Da Silva, É.F.; Hartleben, C.P.; et al. Infection with Leptospira kirschneri Serovar Mozdok: First Report from the Southern Hemisphere. Am. J. Trop. Med. Hyg. 2016, 94, 519–521. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  70. Greenlee, J.J.; Alt, D.P.; Bolin, C.A.; Zuerner, R.L.; Andreasen, C.B. Experimental canine leptospirosis caused by Leptospira interrogans serovars pomona and bratislava. Am. J. Vet. Res. 2005, 66, 1816–1822. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. Goldstein, R.E.; Lin, R.C.; Langston, C.E.; Scrivani, P.V.; Erb, H.N.; Barr, S.C. Influence of infecting serogroup on clinical features of leptospirosis in dogs. J. Vet. Intern. Med. 2006, 20, 489–494. [Google Scholar] [CrossRef] [PubMed]
  72. Rühl-Fehlert, C.I.; Brem, S.; Feller, W.; Kopp, H.; Meyer, P.; Rinke, M. Clinical, microbiological and pathological observations in laboratory beagle dogs infected with leptospires of the serogroup sejroe. Exp. Toxicol. Pathol. 2000, 52, 201–207. [Google Scholar] [CrossRef]
  73. Scanziani, E.; Crippa, L.; Giusti, A.M.; Luini, M.; Pacciarini, M.L.; Tagliabue, S.; Cavalletti, E. Leptospira interrogans serovar sejroe infection in a group of laboratory dogs. Lab. Anim. 1995, 29, 300–306. [Google Scholar] [CrossRef] [PubMed]
  74. Miotto, B.A.; Tozzi, B.F.; de Souza Penteado, M.; Guilloux, A.G.A.; Moreno, L.Z.; Heinemann, M.B.; Moreno, A.M.; Lilenbaum, W.; Hagiwara, M.K. Diagnosis of acute canine leptospirosis using multiple laboratory tests and characterization of the isolated strains. BMC Vet. Res. 2018, 14, 222. [Google Scholar] [CrossRef]
  75. Miotto, B.A.; Moreno, L.Z.; Guilloux, A.G.A.; de Sousa, G.O.; Loureiro, A.P.; Moreno, A.M.; Lilenbaum, W.; Vasconcellos, S.A.; Heinemann, M.B.; Hagiwara, M.K. Molecular and serological characterization of the first Leptospira santarosai strain isolated from a dog. Acta Trop. 2016, 162, 1–4. [Google Scholar] [CrossRef]
  76. Claus, A.; Van de Maele, I.; Pasmans, F.; Gommeren, K.; Daminet, S. Leptospirosis in dogs: A retrospective study of seven clinical cases in Belgium. Vlaams Diergeneeskd. Tijdschr. 2008, 77, 259–263. [Google Scholar]
  77. Fennestad, K.L.; Borg-Petersen, C. Leptospirosis in Danish wild mammals. J. Wildl. Dis. 1972, 8, 343–351. [Google Scholar] [CrossRef] [PubMed]
  78. Borčić, B.; Kovačić, H.; Šebek, Z.; Aleraj, B.; Tvrtković, N. Small terrestrial mammals as reservoirs of leptospires in Sava valley (Croatia). Folia Parasitol. 2005, 29, 177–182. [Google Scholar]
  79. Steinen, A.C.; Schuurman, J.L.; Gravekamp, C.; Korver, H.; Terpstra, W.J. Muskrats as carriers of pathogenic leptospires in The Netherlands. Antonie Van Leeuwenhoek 1992, 61, 43–50. [Google Scholar] [CrossRef]
  80. Korver, H.; Kolk, A.; Vingerhoed, J.; Van Leeuwen, J.; Terpstra, W. Classification of serovars of the icterohaemorrhagiae serogroup by monoclonal antibodies. Isr. J. Vet. 1988, 44, 15–18. [Google Scholar]
  81. Terpstra, W.J.; Korver, H.; Schoone, G.J.; von Leeuwen, J.; Schönemann, C.E.; de Jonge-Aglibut, S.; Kolk, A.H. Comparative classification of Leptospira serovars of the Pomona group by monoclonal antibodies and restriction-endonuclease analysis. Zentralbl. Bakteriol. Mikrobiol. Hyg. A. 1987, 266, 412–421. [Google Scholar] [CrossRef]
  82. Cinco, M.; Banfi, E.; Stornello, C.; Campo, F.; Korver, H. First human isolate of Leptospira interrogans as serovar bratislava in Italy. FEMS Microbiol. Lett. 1989, 47, 499–503. [Google Scholar] [CrossRef]
Figure 1. Geographical distribution of Sequence Types (STs). Locations and amounts of genotyped strains, assessed by Multilocus Sequence Typing (MLST), are reported using ST and province in five regions of Northeast Italy (colored in grey) using pie charts. ST17: L. interrogans serogroup Icterohaemorrhagiae (serovar Icterohaemorrhagiae or Copenhageni); ST24: L. interrogans serogroup Australis (serovar Bratislava or Jalna); ST198: L. interrogans serogroup Australis serovar Australis; ST155: L. borgpetersenii serogroup Sejroe; ST117: L. kirschneri serogroup Pomona serovar Mozdok; ST289: L. kirschneri serogroup Pomona.
Figure 1. Geographical distribution of Sequence Types (STs). Locations and amounts of genotyped strains, assessed by Multilocus Sequence Typing (MLST), are reported using ST and province in five regions of Northeast Italy (colored in grey) using pie charts. ST17: L. interrogans serogroup Icterohaemorrhagiae (serovar Icterohaemorrhagiae or Copenhageni); ST24: L. interrogans serogroup Australis (serovar Bratislava or Jalna); ST198: L. interrogans serogroup Australis serovar Australis; ST155: L. borgpetersenii serogroup Sejroe; ST117: L. kirschneri serogroup Pomona serovar Mozdok; ST289: L. kirschneri serogroup Pomona.
Pathogens 09 00484 g001
Figure 2. Phylogenetic tree constructed using the 3111-bp concatenated MLST loci. The Unweighted Pair Group Method with Arithmetic mean (UPGMA) was used with a bootstrap analysis based on 1000 replicates. Reference strains are indicated by red squares, while field strains are indicated with black squares. The MLVA pattern of each sample is reported on the right (the order of loci is as follows: VNTR-4, -7, -10, Lb4 and Lb5). N: negative.
Figure 2. Phylogenetic tree constructed using the 3111-bp concatenated MLST loci. The Unweighted Pair Group Method with Arithmetic mean (UPGMA) was used with a bootstrap analysis based on 1000 replicates. Reference strains are indicated by red squares, while field strains are indicated with black squares. The MLVA pattern of each sample is reported on the right (the order of loci is as follows: VNTR-4, -7, -10, Lb4 and Lb5). N: negative.
Pathogens 09 00484 g002
Figure 3. Minimum spanning tree based on sequence types (STs). Each circle represents one specific ST (assigned numbers are located outside the circles), and the number of sectors corresponds to the number of samples having this ST. The tree is color-coded according to host. Solid black lines represent branches between STs that differ at one locus, while dotted light-grey lines represent branches between STs differing at more than four loci.
Figure 3. Minimum spanning tree based on sequence types (STs). Each circle represents one specific ST (assigned numbers are located outside the circles), and the number of sectors corresponds to the number of samples having this ST. The tree is color-coded according to host. Solid black lines represent branches between STs that differ at one locus, while dotted light-grey lines represent branches between STs differing at more than four loci.
Pathogens 09 00484 g003
Table 1. Results of real-time PCR performed on canine biological samples.
Table 1. Results of real-time PCR performed on canine biological samples.
UrineBloodKidneyLiverLungBladderSpleenOrgan(s)Not DefinedTotal
No. of Positives/Total162/109566/66575/39223/1157/332/90/612/1480/22347/2485
Percentage of Positives14.8%9.9%18.6%20.0%21.2%22.2%0.0%8.1%0.0%14.0%
Table 2. Isolated samples and their serological typing assessed by the Microscopic Agglutination Test.
Table 2. Isolated samples and their serological typing assessed by the Microscopic Agglutination Test.
No. of IsolatesSpeciesSerogroupSerovar
8L. interrogansIcterohaemorrhagiaeIcterohaemorrhagiae
3L. interrogansIcterohaemorrhagiaeCopenhageni
2L. kirschneriPomonaMozdok
2L. interrogansAustralisAustralis
Table 3. Multilocus Sequence Typing (MLST)-based genotyping using the seven-loci scheme developed by Boonsilp et al. [36].
Table 3. Multilocus Sequence Typing (MLST)-based genotyping using the seven-loci scheme developed by Boonsilp et al. [36].
Genotyped SamplesST 17ST 198ST 24ST 117ST 155ST 289ST 17 LikeTotal
No. of DNA65 (+17)8 (+3)6 (+4)3 (+2)4 (+2)5(1)91 (+29)
No. of Isolates112 2 15
Total76 (+17)10 (+3)6 (+4)5 (+2)4 (+2)5(1)135
The numbers of samples having complete MLST patterns are reported. Numbers in parentheses indicate the additional samples having a partial pattern. ST: sequence type.
Table 4. Vaccination and vital states of sampled dogs and the STs of the infecting Leptospira.
Table 4. Vaccination and vital states of sampled dogs and the STs of the infecting Leptospira.
ST of Infecting LeptospiraVaccination StatusVital StatusTotal
RegularNot RegularUnknownAliveDiedUnknown
24 19 1910
155123 156
2891 4 145
17 Like 1 11
Regular: if the last vaccination occurred less than 12 months before sampling; Not regular: if the vaccination occurred more than 12 months before sampling or never.
Table 5. The lic12008 gene sequencing of strains previously typed as ST17.
Table 5. The lic12008 gene sequencing of strains previously typed as ST17.
No.TypeSpeciesSequence TypeSerovar Definition
By lic12008 SequencingBy MAT
8isolateL. interrogans17IcterohaemorrhagiaeIcterohaemorrhagiae
2IsolateL. interrogans17IcterohaemorrhagiaeCopenhageni
1IsolateL. interrogans17CopenhageniCopenhageni
52DNAL. interrogans17IcterohaemorrhagiaeN.A.
3DNAL. interrogans17CopenhageniN.A.
Serovar identification by lic12008 sequencing and MAT are compared. N.A.: not applicable.
Table 6. Samples submitted for MLST analysis: details of their matrices.
Table 6. Samples submitted for MLST analysis: details of their matrices.
MatrixNo. of DNA Extracted from Biological SamplesNo. of Isolated SamplesTotal
Blood45 45
Kidney34 34
Lung5 5
Organ(s)6 6
Liver4 4
Bladder3 3
Not defined10 10

Share and Cite

MDPI and ACS Style

Bertasio, C.; Boniotti, M.B.; Lucchese, L.; Ceglie, L.; Bellinati, L.; Mazzucato, M.; Furlanello, T.; D’Incau, M.; Natale, A. Detection of New Leptospira Genotypes Infecting Symptomatic Dogs: Is a New Vaccine Formulation Needed? Pathogens 2020, 9, 484.

AMA Style

Bertasio C, Boniotti MB, Lucchese L, Ceglie L, Bellinati L, Mazzucato M, Furlanello T, D’Incau M, Natale A. Detection of New Leptospira Genotypes Infecting Symptomatic Dogs: Is a New Vaccine Formulation Needed? Pathogens. 2020; 9(6):484.

Chicago/Turabian Style

Bertasio, Cristina, Maria Beatrice Boniotti, Laura Lucchese, Letizia Ceglie, Laura Bellinati, Matteo Mazzucato, Tommaso Furlanello, Mario D’Incau, and Alda Natale. 2020. "Detection of New Leptospira Genotypes Infecting Symptomatic Dogs: Is a New Vaccine Formulation Needed?" Pathogens 9, no. 6: 484.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop